Gmp cgmp qa considerations- by Mr. Kailash Vilegave

46

Click here to load reader

Transcript of Gmp cgmp qa considerations- by Mr. Kailash Vilegave

Page 1: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP , CGMP AND QUALITY ASSURANCE

CONSIDERATIONS Mr. Kailash Vilegave

M PharmaLecturer, Dept of Pharmaceutics Shivajirao S. jondhle College of

Pharmacy Asangaon

Page 2: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

INTRODUCTION: Globalization has been the key word in restructuring of the

Indian economy which calls for integration of Indian trade and business with world market.

However, to tap opportunities in the potential world market it is imperative that the manufacturing sector tries to reach the international level in terms of quality, cost, safety, and reliability.

To authenticate organizational standards it would required accreditation from international certification bodies.

The international organization for standardization (ISO) is one such certification level under ISO 9000.

These standers are widely accepted by the lately unified market of the European Economic Community (EEC)

Department of Pharmaceutics [email protected] 2

Page 3: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

Certifacation is the mechanism by which a costimer can have confidance in a compony and is most effective when carried out by a national certification body.

In increasing number of market and third party quality assesment and certifiacation is becoming a prerequisite for doing buisness.

Thus if the compony operates a quality system complying with the standards allows the purchaser to have increased confidence in the quality of the product concerned and the service associated with the suppy of the product

Department of Pharmaceutics [email protected] 3

Page 4: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

EXAMPLE: FDA & industry are in agreement that the consumer

must receive safe, effective, and quality product. Preformulation studies to judge the quality of raw

material. Schedule M – Drug and Cosmetic act 1945 describes

law as “ Good Manufacturing Practices & requirements of premises, plant and equipment.”

Rule 71 of Drug and Cosmetic act 1945 clearly specifies the condition for grant or renewal of license in form 25 (25F)

Department of Pharmaceutics [email protected] 4

Page 5: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

WHAT IS GMP ? GMP is that part of Quality assurance which

ensures that the products are consistently manufactured and controlled to the Quality standards appropriate to their intended use

"GMP" - A set of principles and procedures which, when followed by manufacturers for therapeutic goods, helps ensure that the products manufactured will have the required quality.

"GMP“ – provides specific gudelines to serve to checks for criticle operation within the organisation so that a total quality controll system can be achieved

Department of Pharmaceutics [email protected] 5

Page 6: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

OBJECTIVES OF GMP T Q M Zero deffect product Withstand in global market Safty & efficacy in the entire organization. Efficient operation during work process.

Department of Pharmaceutics [email protected] 6

Page 7: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

ADVANTAGES OF GMP 20-25 % increase productivity 40-50%reduction in work in process due to more

efficient & swifter technique. Decrease manufacturing cost Avoidance of accident within entire organization. Personnel hygiene and health is achieved.

Department of Pharmaceutics [email protected] 7

Page 8: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

WHAT IS CGMP ? Usually see “cGMP” – where c = current, to

emphasize that the expectations are dynamic

In this some aditional guidelines for Manufacturing, Packaging, Storage & installation of medicle servises into organisation.

C GMP may also be viewed as consisting of the following four essential elements.

4 ‘ P ’s –1.Personnels2.Parts3.Process4.Procedures

Department of Pharmaceutics [email protected] 8

Page 9: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

1.Personnels:The people system and manpower required to carryout the

various tasks within the manufacturing and control function.2. Parts:

The raw material and components used in connection with the manufacture and packaging of the drug product as well as the material used in association with the control.

3. Process:

The building, facilities, equipments instrumentation and support systems (heat, air, vacuum, water, & lighting ) used in connection with the manufacturing process and the control.

4. procedure:

the paper work, documentation of records used in connection with the manufacturing process and its control

Department of Pharmaceutics [email protected] 9

4 ‘ P ’s essential Element to represent CGMP

Page 10: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QUALITY DEFINITION Quality of a medicinal product is measured by it’s

fitness for purpose . Safety and efficacy are not separable from Quality but part of it

Quality = Safety + Efficacy + Purity

Department of Pharmaceutics [email protected] 10

Page 11: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

Department of Pharmaceutics [email protected] 11

Page 12: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GOOD MANUFACTURING PRACTICES

A basic tenet of GMP is that quality cannot be tested into a batch of product but must be built into each batch of product during all stages of the manufacturing process.

It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.

Department of Pharmaceutics [email protected] 12

Page 13: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

SOME OF THE MAIN RISKS ARE

unexpected contamination of products, causing damage to health or even death.

incorrect labels on containers, which could mean that patients receive the wrong medicine.

insufficient or too much active ingredient, resulting in ineffective treatment or adverse effects. Department of Pharmaceutics

[email protected] 13

Page 14: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP HELPS BOOST PHARMACEUTICAL EXPORT OPPORTUNITIES

Most countries will only accept import and sale of medicines that have been manufactured to internationally recognized GMP.

Governments seeking to promote their countries export of pharmaceuticals can do so by making GMP mandatory for all pharmaceutical production and by training their inspectors in GMP requirements.

Department of Pharmaceutics [email protected] 14

Page 15: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP COVERS… ALL aspects of production; from the starting materials,

premises and equipment to the training and personal hygiene of staff.

Detailed, written procedures are essential for each process that could affect the quality of the finished product.

There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made.

Department of Pharmaceutics [email protected] 15

Page 16: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP The Quality of a formulation or a bulk drug depends

on the Quality of those producing it

GMP is the magic key that opens the door of the Quality

In matter of GMP, swim with the current and in matter of Quality stand like a rock!

Department of Pharmaceutics [email protected] 16

Page 17: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QA, GMP & QC INTER-RELATIONSHIP

Department of Pharmaceutics [email protected] 17

QC

GMP

QA

Page 18: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QA, GMP & QC INTER-RELATIONSHIP

It is the sum total of the organized arrangements with the objective of ensuring that products will be of the quality required

for their intended use

Department of Pharmaceutics [email protected] 18

QA

Page 19: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QA, GMP & QC INTER-RELATIONSHIP

Is that part of Quality Assurance aimed at ensuring that products

are consistently manufactured to a quality appropriate to their

intended use

Department of Pharmaceutics [email protected] 19

GMP

Page 20: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QA, GMP & QC INTER-RELATIONSHIP

Is that part of GMP concerned with sampling, specification & testing,

documentation & release procedures which ensure that the

necessary & relevant tests are performed & the product is released

for use only after ascertaining it’s quality

Department of Pharmaceutics [email protected] 20

QC

Page 21: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QC AND QA

QC is that part of GMP which is concerned with sampling,

specifications, testing and with in the organization, documentation,and release procedures which ensure that the necessary and relevant tests are carried out

QA is the sum total of organized arrangements made with the object of ensuring that product will be of the Quality required by their intended use.

Department of Pharmaceutics [email protected] 21

Page 22: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QC AND QA

Operational laboratory techniques and activities used to fulfill the requirement of Quality

All those planned or systematic actions necessary to provide adequate confidence that a product will satisfy the requirements for quality

Department of Pharmaceutics [email protected] 22

Page 23: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

QC AND QA

QC is lab based QA is company based

Department of Pharmaceutics [email protected] 23

Page 24: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP GUIDELINES GMP as per Schedule “M” www.cdsco.nic.in GMP as per WHO www.who.int GMP as per MCA now known as MHRA www.mca.gov.uk GMP as per TGA www.tga.gov.au GMP as per US FDA www.fda.gov GMP as per ICH guidelines www.ich.org

Department of Pharmaceutics [email protected] 24

Page 25: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP

GMP in solid dosage forms GMP in semisolid dosage forms GMP in Liquid orals GMP in Parenterals Production GMP in Ayurvedic medicines GMP in Bio technological products GMP in Nutraceuticals and cosmeceuticals GMP in Homeopathic medicines

Department of Pharmaceutics [email protected] 25

Page 26: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP

Good Manufacturing Practice Good Management Practice Get More Profit Give more Production GMP Training with out tears

Department of Pharmaceutics [email protected] 26

Page 27: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

GMP

All past GMPs are history….It is looking like in rear view mirror and driving

Department of Pharmaceutics [email protected] 27

Page 28: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

TEN PRINCIPLES OF GMP1. Design and construct the facilities and equipments properly2. Follow written procedures and Instructions3. Document work4. Validate work5. Monitor facilities and equipment6. Write step by step operating procedures and work on

instructions7. Design ,develop and demonstrate job competence8. Protect against contamination9. Control components and product related processes 10. Conduct planned and periodic audits

Department of Pharmaceutics [email protected] 28

Page 29: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

BEYOND GMP

Reduce pollution - Zero discharge Adaptation of environment friendly methods Consideration for better and healthier life

tomorrow Consideration of ethics in life One should begin with end in mind otherwise it

will be the beginning of the end

Department of Pharmaceutics [email protected] 29

Page 30: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

COST OF EFFECTIVE GMP In fact Cost benefits – positive cost benefits of

GMP/QA Good plant lay out, Smooth work flows, Efficient

documentation systems, well controlled process, good stores lay outs and stores records- These are Good manufacturing practices

Reduction in work in process and inventory holding costs

Avoidance of cost of Quality failure ( cost of waste, of rework, of recall, of consumer compensation and of loss of company reputation)

Department of Pharmaceutics [email protected] 30

Page 31: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

LIST OF IMPORTANT DOCUMENTS IN GMP

Policies SOP Specifications MFR (Master Formula Record) BMR Manuals Master plans/ files Validation protocols Forms and Formats Records

Department of Pharmaceutics [email protected] 31

Page 32: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

10 ATTRIBUTES OF A GOOD DOCUMENT

1. Accurate2. Clear3. Complete4. Consistent5. Indelible6. Legible7. Timely8. Direct 9. Authentic10. Authorized

Department of Pharmaceutics [email protected] 32

Page 33: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

CERTIFYING AGENCIES ICH. www.ich.org

WHO. www.who.int

US FDA. www.fda.gov

EU/EMEA. www.emea.europa.eu

Department of Pharmaceutics [email protected] 33

Page 34: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

HOW DO GMPS OF DIFFERENT COUNTRIES COMPARE?

At a high level, GMPs of various nations are very similar; most require things like:

Equipment and facilities being properly designed, maintained, and cleaned Standard Operating Procedures (SOPs) be written and approved An independent Quality unit (like Quality Control and/or Quality Assurance) Well trained personnel and management

Department of Pharmaceutics [email protected] 34

Page 35: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

CGMP FOR FINISHED PHARMACEUTICALS

1. General Provision2. Organization & Personnel3. Building & Facilities4. Equipment5. Control of Components & Drug Product Containers &

Closures6. Production & Process Control7. Packaging & Labeling Control8. Handling & Distribution9. Laboratory Control10. Records & Reports11. Returned & Salvaged Drugs

Department of Pharmaceutics [email protected] 35

Page 36: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

ORGANIZATION & PERSONNEL

1. Responsibilities of quality control unit.

2. Personnel qualifications.

3. Personnel responsibilities.

4. Consultants.

Department of Pharmaceutics [email protected] 36

Page 37: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

BUILDING & FACILITIES

1. Design and construction features. 2. Lighting.3. Ventilation, air filtration, air heating

and cooling. 4. Plumbing. 5. Sewage and refuse. 6. Washing and toilet facilities. 7. Sanitation. 8. Maintenance.

Department of Pharmaceutics [email protected] 37

Page 38: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

EQUIPMENT

1. Equipment design, size, and location. 2. Equipment construction. 3. Equipment cleaning and maintenance. 4. Automatic, mechanical, and electronic

equipment. 5. Filters.

Department of Pharmaceutics [email protected] 38

Page 39: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

CONTROL OF COMPONENTS & DRUG PRODUCT CONTAINERS & CLOSURES

1. General requirements. 2. Receipt & storage of untested

components, drug product containers, and closures.

3. Testing and approval or rejection of components, drug product containers, and closures.

4. Use of approved components, drug product containers, and closures.

5. Retesting of approved components, drug product containers, and closures.

6. Rejected components, drug product containers, and closures.

7. Drug product containers and closures. Department of Pharmaceutics

[email protected] 39

Page 40: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

PRODUCTION & PROCESS CONTROL

1. Written procedures; deviations. 2. Charge-in of components.3. Calculation of yield. 4. Equipment identification. 5. Sampling and testing of in-process

materials and drug products. 6. Time limitations on production. 7. Control of microbiological

contamination.8. Reprocessing.

Department of Pharmaceutics [email protected] 40

Page 41: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

PACKAGING & LABELING CONTROL

1. Materials examination and usage criteria.

2. Labeling issuance. 3. Packaging and labeling operations. 4. Tamper-evident packaging

requirements for over-the-counter (OTC) human drug products.

5. Drug product inspection. 6. Expiration dating.

Department of Pharmaceutics [email protected] 41

Page 42: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

HANDLING & DISTRIBUTION

1. Warehousing procedures.

2. Distribution procedures.

Department of Pharmaceutics [email protected] 42

Page 43: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

LABORATORY CONTROL

1. General requirements. 2. Testing and release for distribution. 3. Stability testing. 4. Special testing requirements. 5. Reserve samples. 6. Laboratory animals. 7. Penicillin contamination.

Department of Pharmaceutics [email protected] 43

Page 44: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

RECORDS & REPORTS

1. General requirements. 2. Equipment cleaning and use log. 3. Component, drug product container,

closure, and labeling records. 4. Master production and control records. 5. Batch production and control records. 6. Production record review. 7. Laboratory records. 8. Distribution records. 9. Complaint files.

Department of Pharmaceutics [email protected] 44

Page 45: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

RETURNED & SALVAGED DRUG PRODUCTS

1. Returned drug products. 2. Drug product salvaging.

Department of Pharmaceutics [email protected] 45

Page 46: Gmp cgmp  qa considerations- by Mr. Kailash Vilegave

Department of Pharmaceutics [email protected] 46